Protalix BioTherapeutics (PLX) Reports FY Loss of $0.08
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.16 -2.7%
EPS Growth %: +400.0%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +400.0%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported FY EPS of ($0.08). Revenue for the period came in at $52.74 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Lockheed Martin wins $83 million Army missile contract
- Rocket Lab launches U.S. Space Force mission in record 16 hours
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
